Journal article icon

Journal article

Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin.

Abstract:

Intravenous immunoglobulin (IVIG) is used as the standard replacement therapy for patients with primary antibody deficiencies. A previous study of adverse reactions in patients self-infusing at home over 1 year showed an overall reaction rate of 0.7%. A larger prospective study is reported here, involving a greater number of immunology centres and including children and adults who received infusions from medical or nursing staff as well as those self-infusing. Four hundred and fifty-nine pati...

Expand abstract

Actions


Access Document


Authors


Brennan, VM More by this author
Salomé-Bentley, NJ More by this author
Chapel, HM More by this author
Journal:
Clinical and experimental immunology
Volume:
133
Issue:
2
Pages:
247-251
Publication date:
2003-08-05
DOI:
EISSN:
1365-2249
ISSN:
0009-9104
URN:
uuid:22b111dc-c8c2-4734-8db8-c424fc2ac9fb
Source identifiers:
94164
Local pid:
pubs:94164

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP